Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2026-01-01 @ 4:40 PM
Study NCT ID:
NCT01943032
Status:
COMPLETED
Last Update Posted:
2013-09-20
First Post:
2013-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Discordant Hormonal Status of Breast Cancer.
Sponsor:
National Cancer Institute, Thailand
Organization:
Study Overview
Official Title:
Discordant Hormonal Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.
Status:
COMPLETED
Status Verified Date:
2013-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine discordant hormonal status of primary breast tumor and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer patients.
Detailed Description:
Hormonal status between primary breast tumor and axillary lymph node were analyzed.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: